Processa Pharmaceuticals logo

Processa Pharmaceuticals Share Price Today

(NASDAQ: PCSA)

Processa Pharmaceuticals share price is $0.51 & ₹44.35 as on 6 Mar 2025, 2.30 'hrs' IST

$0.51

0.02

(3.81%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Processa Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Processa Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Processa Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Processa Pharmaceuticals share price movements

  • Today's Low: $0.46
    Today's High: $0.52

    Day's Volatility :11.35%

  • 52 Weeks Low: $0.47
    52 Weeks High: $3.31

    52 Weeks Volatility :85.78%

Processa Pharmaceuticals (PCSA) Returns

PeriodProcessa Pharmaceuticals IncIndex (Russel 2000)
3 Months
-52.17%
0.0%
6 Months
-62.85%
0.0%
1 Year
-78.87%
0.0%
3 Years
-99.3%
-11.6%

Processa Pharmaceuticals (PCSA) Key Statistics

in dollars & INR

Previous Close
$0.4903
Open
$0.4903
Today's High
$0.516651
Today's Low
$0.458
Market Capitalization
$2.3M
Today's Volume
$2.9K
52 Week High
$3.305
52 Week Low
$0.458
Revenue TTM
$0.0
EBITDA
$-11.8M
Earnings Per Share (EPS)
$-4.8
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-211.71%

How to invest in Processa Pharmaceuticals Stock (PCSA) from India?

It is very easy for Indian residents to invest directly in Processa Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Processa Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Processa Pharmaceuticals or PCSA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Processa Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Processa Pharmaceuticals shares which would translate to 1.705 fractional shares of Processa Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Processa Pharmaceuticals, in just a few clicks!

Returns in Processa Pharmaceuticals (PCSA) for Indian investors in Rupees

The Processa Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Processa Pharmaceuticals investment value today

Current value as on today

₹26,946

Returns

₹73,054

(-73.05%)

Returns from Processa Pharmaceuticals Stock

₹78,017 (-78.02%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Processa Pharmaceuticals (PCSA)

27%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Processa Pharmaceuticals Stock from India on INDmoney has increased by 27% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Processa Pharmaceuticals

  • HRT FINANCIAL LLC

    0.67%

  • Vanguard Group Inc

    0.52%

  • Geode Capital Management, LLC

    0.46%

  • Miracle Mile Advisors, INC.

    0.21%

  • UBS Group AG

    0.17%

  • Tower Research Capital LLC

    0.05%

Analyst Recommendation on Processa Pharmaceuticals

Buy

    77%Buy

    22%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Processa Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
6
0
Hold
2
2
3
Sell
0
0
3

Analyst Forecast on Processa Pharmaceuticals Stock (PCSA)

What analysts predicted

Upside of 1076.47%

Target:

$6.00

Current:

$0.51

Insights on Processa Pharmaceuticals Stock (Ticker Symbol: PCSA)

  • Price Movement

    In the last 3 months, PCSA stock has moved down by -52.2%
  • PCSA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 140.8%
  • PCSA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 147.0%

Processa Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Processa Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Processa Pharmaceuticals (PCSA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Processa Pharmaceuticals Inc logo
-28.11%
-62.85%
-78.87%
-99.3%
-99.38%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Processa Pharmaceuticals Inc logo
NA
NA
NA
-4.05
-2.12
-1.13
NA
1.14
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Processa Pharmaceuticals Inc logo
Buy
$2.3M
-99.38%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Processa Pharmaceuticals

Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment. Its drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms of killing the cancer cells. The company's pipeline includes three chemotherapy drugs comprising Gemcitabine, PCS3117 that has completed Phase 2a clinical trials to treat pancreatic, biliary tract, lung, ovarian, breast, and other cancers; Capecitabine, a combination of PCS6422 and capecitabine that has completed Phase 1b clinical trials to treat metastatic colorectal, gastrointestinal, breast, pancreatic, and other cancers; and Irinotecan, PCS11T that is in pre-clinical studies to treat lung, colorectal, gastrointestinal, pancreatic, and other cancers. It also develops non-oncology drugs consisting of PCS12852 for treatment of gastroparesis; and PCS499 to treat patients with ulcerative and non-ulcerative necrobiosis lipoidica. The company has license agreements with Elion Oncology, Inc.; Ocuphire Pharma, Inc.; Aposense, Ltd.; Yuhan Corporation; and CoNCERT Pharmaceuticals, Inc. Processa Pharmaceuticals, Inc. was founded in 2011 and is based in Hanover, Maryland.
Organization
Processa Pharmaceuticals
Employees
13
CEO
Mr. George K. Ng Esq., J.D.
Industry
Industrial Machinery

Management People of Processa Pharmaceuticals

NameTitle
Mr. George K. Ng Esq., J.D.
CEO & Director
Dr. David Young Ph.D., Pharm.D.
Co-Founder, President of Research and Development & Director
Dr. Sian E. Bigora Ph.D., Pharm.D.
Co-Founder and Chief Development & Regulatory Officer
Mr. Patrick Lin
Co-Founder, Chief Business & Strategy Officer
Ms. Wendy J. Guy
Co-Founder, Chief Administrative Officer & Corporate Secretary
Mr. Russell L. Skibsted M.B.A.
Chief Financial Officer
Dr. Steven Cha M.D.
Senior Vice President of Clinical Research

Important FAQs about investing in PCSA Stock from India :

What is Processa Pharmaceuticals share price today?

Processa Pharmaceuticals share price today stands at $0.51, Open: $0.49 ; Previous Close: $0.49 ; High: $0.52 ; Low: $0.46 ; 52 Week High: $3.31 ; 52 Week Low: $0.47.

The stock opens at $0.49, after a previous close of $0.49. The stock reached a daily high of $0.52 and a low of $0.46, with a 52-week high of $3.31 and a 52-week low of $0.47.

Can Indians buy Processa Pharmaceuticals shares?

Yes, Indians can invest in the Processa Pharmaceuticals (PCSA) from India.

With INDmoney, you can buy Processa Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Processa Pharmaceuticals at zero transaction cost.

How can I buy Processa Pharmaceuticals shares from India?

It is very easy to buy Processa Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Processa Pharmaceuticals (PCSA) be purchased?

Yes, you can buy fractional shares of Processa Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Processa Pharmaceuticals stocks?

To start investing in Processa Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Processa Pharmaceuticals Stock (PCSA)?

Today’s highest price of Processa Pharmaceuticals (PCSA) is $0.52.

Today’s lowest price of Processa Pharmaceuticals (PCSA) is $0.46.

What is today's market capitalisation of Processa Pharmaceuticals?

Today's market capitalisation of Processa Pharmaceuticals PCSA is 2.3M

What is the 52 Week High and Low Range of Processa Pharmaceuticals Stock (PCSA)?

  • 52 Week High

    $3.31

  • 52 Week Low

    $0.47

What are the historical returns of Processa Pharmaceuticals (PCSA)?

  • 1 Month Returns

    -28.11%

  • 3 Months Returns

    -62.85%

  • 1 Year Returns

    -78.87%

  • 5 Years Returns

    -99.38%

Who is the Chief Executive Officer (CEO) of Processa Pharmaceuticals ?

Mr. George K. Ng Esq., J.D. is the current Chief Executive Officer (CEO) of Processa Pharmaceuticals.